Regulus Therapeutics (RGLS)
(Delayed Data from NSDQ)
$2.21 USD
-0.04 (-1.78%)
Updated May 10, 2024 04:00 PM ET
After-Market: $2.20 -0.01 (-0.45%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, Regulus Therapeutics (RGLS) reported earnings of -$0.29 per share, missing the Zacks Consensus Estimate of -$0.15 per share. This reflects a negative earnings surprise of 93.33%. Look out for RGLS's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year increase of 67.57%.
Earnings History
Price & Consensus
Zacks News for RGLS
Regulus (RGLS) Up 71% on Topline Data from Kidney Disease Study
RGLS: What are Zacks experts saying now?
Zacks Private Portfolio Services